Skip to main content
September 29, 2022
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Home
Myeloproliferative Neoplasms
Myeloproliferative Neoplasms Overviews
Myeloproliferative Neoplasms Survivorship
Myeloproliferative Neoplasms Treatment
Myeloproliferative Neoplasms Treatment
Myeloproliferative Neoplasms Treatment
Treatment & Care
COVID-19 Vaccines and Cancer - Evushield "Authorized"
By Dr. C.H. Weaver M.D.
Aug 6, 2022
Myeloproliferative Neoplasms Overviews
Treatment of Myelofibrosis
By Dr. C.H. Weaver M.D.
Aug 5, 2022
Myeloproliferative Neoplasms Treatment
Overview of Polycythemia Vera
By Dr. C.H. Weaver M.D.
Aug 5, 2022
Myeloproliferative Neoplasms Overviews
Ask The Experts About COVID-19 and Myeloproliferative Neoplasms (MF - PV - ET)
By Dr. C.H. Weaver M.D.
Aug 5, 2022
Myeloproliferative Neoplasms Treatment
Symptomatic Polycythemia Vera Patients May Benefit From Treatment
By Dr. C.H. Weaver M.D.
Aug 5, 2022
Myeloproliferative Neoplasms Treatment
Jakafi/Selinexor combination evaluated in myelofibrosis
By Dr. C.H. Weaver M.D.
Aug 3, 2022
Myeloproliferative Neoplasms Treatment
Momelotinib Granted FDA Fast Track Designation for Myelofibrosis
By MedMaven
Jun 17, 2022
Myeloproliferative Neoplasms Treatment
BET Inhibitors Treatment of Myelofibrosis
By Dr. C.H. Weaver M.D.
Jun 14, 2022
Myeloproliferative Neoplasms Treatment
Navitoclax-Jakafi combo being evaluated in myelofibrosis
By Dr. C.H. Weaver M.D.
Apr 18, 2022
Myeloproliferative Neoplasms Treatment
New Treatment Regimen Improves Jakafi Associated Side Effects
By MedMaven
Mar 20, 2022
Myeloproliferative Neoplasms Treatment
Progress on Pacritinib Development for Treatment of Myelofibrosis
By Dr. C.H. Weaver M.D.
Mar 5, 2022
Myeloproliferative Neoplasms
Myeloproliferative Neoplasm Update ASH 2021
By Dr. C.H. Weaver M.D.
Dec 16, 2021
Myeloproliferative Neoplasms Treatment
Interferon in The Management of PV and ET
By Dr. C.H. Weaver M.D.
Nov 14, 2021
Myeloproliferative Neoplasms Treatment
Dacogen Effective in Advanced Phases of MPN
By Dr. C.H. Weaver M.D.
Sep 20, 2021
Myeloproliferative Neoplasms Treatment
Jakafi Superior to Standard Therapy for Polycythemia Vera
By Dr. C.H. Weaver M.D.
Sep 11, 2021
Myeloproliferative Neoplasms Survivorship
Diagnosed with an MPN? Consider a Second Opinion and See an Expert!
By Dr. C.H. Weaver M.D.
Aug 19, 2021
Myeloproliferative Neoplasms Treatment
Inrebic (fedratinib) Treatment of Myelofibrosis
By Dr. C.H. Weaver M.D.
Aug 14, 2021
Myeloproliferative Neoplasms Treatment
Imetelstat for Myelofibrosis
By Dr. C.H. Weaver M.D.
Aug 13, 2021
Myeloproliferative Neoplasms Treatment
Rusfertide Eliminates Need for Phlebotomy, Reverses Iron Deficiency in Polycythemia Vera
By Dr. C.H. Weaver M.D.
Jun 17, 2021
Myeloproliferative Neoplasms Treatment
Jakafi Rechallenge May Improve Survival in Patients with Myelofibrosis
By Dr. C.H. Weaver M.D.
May 5, 2021
Myeloproliferative Neoplasms Treatment
Long Term Survival in Myelofibrosis Improved with Early Use of Jakafi®
By CancerConnect
Apr 29, 2021
Myeloproliferative Neoplasms Treatment
New Treatment Strategies for Jakafi Experienced Patients with Myelofibrosis
By Dr. C.H. Weaver M.D.
Apr 28, 2021
Myeloproliferative Neoplasms Treatment
Over the Counter Combo Helps Control Itching
By CancerConnect
Apr 4, 2020
Myeloproliferative Neoplasms Treatment
Ask the Expert Advances in the Management of Myeloproliferative Neoplasms
By TraceyS
Jan 1, 2020
Myeloproliferative Neoplasms Treatment
September Is National Blood Cancer Awareness Month
By CancerConnect
Aug 29, 2019
Myeloproliferative Neoplasms Treatment
Idasanutlin Treatment for Polycythemia Vera and Essential Thrombocytopenia
By MedMaven
Jul 24, 2019
Myeloproliferative Neoplasms Treatment
AVID200, a Novel TGF-beta 1 & 3 Inhibitor Begins Evaluation in Myelofibrosis
By MedMaven
May 7, 2019
Myeloproliferative Neoplasms Treatment
Daurismo Evaluated in Myelofibrosis
By MedMaven
Apr 2, 2019
Myeloproliferative Neoplasms Treatment
Thalidomide - Jakafi Combo A Novel Approach for Treatment of Myelofibrosis
By MedMaven
Feb 22, 2019
Myeloproliferative Neoplasms Treatment
Jakafi-Interferon Combination “RUXOPEG” Promising for Treatment of Myelofibrosis
By MedMaven
Jan 31, 2019
Myeloproliferative Neoplasms Treatment
The CancerConnect Myeloproliferative Neoplasms MPN Newsletter
By MedMaven
Nov 15, 2018
Myeloproliferative Neoplasms Treatment
Spleenomegaly from Myelofibrosis Improved with Jakafi
By CancerConnect
Sep 28, 2018
Myeloproliferative Neoplasms Treatment
Research Suggests JAK Inhibitors May Cause Aggressive Lymphoma
By CancerConnect
Jun 18, 2018
Myeloproliferative Neoplasms Treatment
Incyte Announces Initiation of Clinical Trial Evaluating Jakafi®
By CancerConnect
Nov 22, 2017
Myeloproliferative Neoplasms Treatment
International Marrow Donor Registries Reach 25 Million Potential Donors
By CancerConnect
Apr 1, 2015
Myeloproliferative Neoplasms Treatment
Protein Inhibitor INCB039110 Appears Active in Myelofibrosis
By CancerConnect
Jan 6, 2015
Myeloproliferative Neoplasms Treatment
Jakafi® Appears Effective in the Treatment of Essential Thrombocythemia
By CancerConnect
Dec 11, 2014
Myeloproliferative Neoplasms Treatment
Jakafi: First Drug Approved for Treatment of Polycythemia Vera
By CancerConnect
Dec 5, 2014
Myeloproliferative Neoplasms Treatment
Jakafi® (ruxolitinib) Product Label Expanded to Include Safety and Dosing Info.
By CancerConnect
Jul 30, 2014
Myeloproliferative Neoplasms Treatment
New Gene Mutation Identified in Myeloproliferative Neoplasms
By CancerConnect
Dec 31, 2013
CLOSE
CLOSE
CLOSE
CLOSE
